|Articles|June 1, 2002
Primary therapy with SLT has potential for durable efficacy
Boston-Selective laser trabeculoplasty (SLT) is safe and effective as initial treatment for primary open-angle glaucoma (POAG) or pseudoexfoliation (PXF) glaucoma, and it can maintain IOP control in some eyes for 30 months or longer, said Mark A. Latina, MD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Physician perspective: Glaucoma eye drops are here to stay
2
SparingVision completes PRODYGY trial patient dosing with SPVN06
3
American College of Physicians Calls for An End of the Term 'Provider' in Policy Paper
4
PRIMA System: A major step in the battle against GA
5
























